{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T20:12:19Z","timestamp":1770581539447,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jcf.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T08:30:21Z","timestamp":1386750621000},"page":"424-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prescribing practices for intravenous aminoglycosides in UK Cystic Fibrosis clinics: A questionnaire survey"],"prefix":"10.1016","volume":"13","author":[{"given":"Alan R.","family":"Smyth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2013.11.007_bb0005","series-title":"Annual Data Report 2011","article-title":"UK CF Registry","author":"U.K. Cystic Fibrosis Trust","year":"2013"},{"key":"10.1016\/j.jcf.2013.11.007_bb0010","series-title":"Report of the UK cystic fibrosis trust antibiotic group","article-title":"Antibiotic treatment for cystic fibrosis","year":"2009"},{"key":"10.1016\/j.jcf.2013.11.007_bb0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thx.2007.088757","article-title":"Case\u2013control study of acute renal failure in patients with cystic fibrosis in the UK","volume":"63","author":"Smyth","year":"2008","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2013.11.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002009.pub4","article-title":"Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis","author":"Smyth","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2013.11.007_bb0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2013.11.007_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ppul.10036","article-title":"To the editor: lack of concordance in the use and monitoring of intravenous aminoglycosides in UK cystic fibrosis centers","volume":"33","author":"Tan","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.11.007_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis\u2014the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2013.11.007_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta-analysis","volume":"312","author":"Barza","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2013.11.007_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1445-5994.2001.00010.x","article-title":"Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia","volume":"31","author":"Phillips","year":"2001","journal-title":"Intern Med J"},{"key":"10.1016\/j.jcf.2013.11.007_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1445-5994.2008.01787.x","article-title":"Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?","volume":"39","author":"Soulsby","year":"2009","journal-title":"Intern Med J"}],"updated-by":[{"DOI":"10.1016\/j.jcf.2014.09.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000}}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199313001975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199313001975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T08:21:02Z","timestamp":1538986862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199313001975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1569199313001975"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2013.11.007","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jcf.2014.09.001","asserted-by":"object"}]},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing practices for intravenous aminoglycosides in UK Cystic Fibrosis clinics: A questionnaire survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}